Literature DB >> 8917921

Prediction of results from correspondence treatment for controlled drinking.

D J Kavanagh1, T Sitharthan, G P Sayer.   

Abstract

Identification of people who will benefit most from brief interventions is an important research challenge in the study of addictive disorders. The current study investigated predictors of response to correspondence interventions for alcohol abuse. We examined both subject retention and alcohol intake over a 12-month period. The primary focus was on the predictive utility of self-efficacy, stages of change and alcohol dependence. Self-efficacy performed relatively well in the study, predicting both retention and later consumption. When predicting 12-month consumption from pretest assessments or examining subject retention over the last 6 months, self-efficacy offered a significant contribution to multivariate analyses. However, in some other predictions a significant effect of self-efficacy was eliminated after the entry of other variables. Stages of change significantly predicted mid-way through treatment, but did not provide an independent prediction of overall retention or treatment response. Neither the degree of alcohol dependence nor level of alcohol problems figured in any of the predictions. Older subjects stayed longer in the study, and those with lower intake and higher pretest self-efficacy had the lowest consumption at 12 months. Results are compared with previous research on prediction of outcomes in addictive disorders.

Entities:  

Mesh:

Year:  1996        PMID: 8917921

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  9 in total

1.  Self-efficacy for cocaine abstinence: pretreatment correlates and relationship to outcomes.

Authors:  Sara L Dolan; Rosemarie A Martin; Damaris J Rohsenow
Journal:  Addict Behav       Date:  2007-12-07       Impact factor: 3.913

2.  A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults.

Authors:  Mikhail N Koffarnus; Conrad J Wong; Karly Diemer; Mick Needham; Jacqueline Hampton; Michael Fingerhood; Dace S Svikis; George E Bigelow; Kenneth Silverman
Journal:  Alcohol Alcohol       Date:  2011-05-27       Impact factor: 2.826

3.  Motivation and self-efficacy in the context of moderated drinking: global self-report and ecological momentary assessment.

Authors:  Alexis Kuerbis; Stephen Armeli; Frederick Muench; Jon Morgenstern
Journal:  Psychol Addict Behav       Date:  2012-12-31

4.  Profiles of confidence and commitment to change as predictors of moderated drinking: a person-centered approach.

Authors:  Alexis Kuerbis; Stephen Armeli; Frederick Muench; Jon Morgenstern
Journal:  Psychol Addict Behav       Date:  2014-08-18

Review 5.  The role of self-efficacy in the treatment of substance use disorders.

Authors:  Ronald M Kadden; Mark D Litt
Journal:  Addict Behav       Date:  2011-07-29       Impact factor: 3.913

6.  Integrative data analysis of self-efficacy in 4 clinical trials for alcohol use disorder.

Authors:  Eric S Kruger; Kelsey N Serier; Rory A Pfund; James R McKay; Katie Witkiewitz
Journal:  Alcohol Clin Exp Res       Date:  2021-09-30       Impact factor: 3.455

7.  Motivation to reduce alcohol consumption and subsequent attempts at reduction and changes in consumption in increasing and higher-risk drinkers in England: a prospective population survey.

Authors:  Frank de Vocht; Jamie Brown; Emma Beard; Robert West; Susan Michie; Rona Campbell; Matthew Hickman
Journal:  Addiction       Date:  2018-01-25       Impact factor: 6.526

8.  Procrastination and Self-Efficacy Among Intravenous Drug Users on a Methadone Maintenance Program in Sari City, Iran, 2013.

Authors:  Fatemeh Taghizadeh; Jamshid Yazdani Cherati
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-12-23

9.  Social robots as treatment agents: Pilot randomized controlled trial to deliver a behavior change intervention.

Authors:  Nicole L Robinson; Jennifer Connolly; Leanne Hides; David J Kavanagh
Journal:  Internet Interv       Date:  2020-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.